Background: In May 2010, the Centers for Disease Control and Prevention (CDC) released the US Medical Eligibility Criteria for Contraceptive Use (MEC) to provide evidence-based guidance on contraceptive safety in US women with medical conditions. The CDC MEC was adapted from similar World Health Organization (WHO) guidelines.
Methods: A total of 754 US obstetrician-gynecologists, family physicians, and internists were surveyed at national conferences specific to each specialty between April and September 2011. The survey assessed prior use of the WHO and CDC MEC and provided case questions to answer using the CDC MEC guidelines.
Results: The respondents included 190 (25%) obstetrician-gynecologists, 326 (43%) family physicians, and 239 (32%) internists. Only 39% of respondents had heard of either MEC, and only 23% had previously used one or both MECs. Among the 120 (16%) respondents who had previously used the CDC MEC, utilization rates differed significantly by specialty (27%, 12%, and 13%, respectively) but not by gender. When the CDC MEC was provided for participants to use for two case questions, only 39% and 80% of participants gave correct answers.
Conclusions: Although the CDC MEC is designed to be used regularly by primary care and specialty physicians, relatively few used it in the first year after its release. Even when the CDC MEC is provided to assist in answering case questions, physicians appear to have difficulty answering correctly. More work is needed to disseminate and clarify the CDC MEC.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
LEVONORGESTREL INTRAUTERINE DEVICE PLACEMENT IN UTERINE ANOMALIES: A CASE SERIES.
J Pediatr Adolesc Gynecol
December 2024
Children's Minnesota Department of Pediatric and Adolescent Gynecology.
Background: Levonorgestrel intrauterine devices (IUDs) provide effective contraception and medical benefits. They are safe for even severely medically complex patients. The CDC Medical Eligibility Criteria (MEC) states IUDs are category 4 for people with uterine cavity distortions, however there are previous case reports of their successful use in this population.
View Article and Find Full Text PDFSubstance use and help seeking as coping behaviors among parents and unpaid caregivers of adults in the United States during the COVID-19 pandemic.
Am J Drug Alcohol Abuse
November 2024
Centers for Disease Control and Prevention, Atlanta, GA, USA.
During the COVID-19 pandemic, caregiving responsibilities may have been associated with increased substance use. To characterize substance use to cope with stress and willingness to seek help among (i) parents, (ii) unpaid caregivers of adults, and (iii) parent-caregivers. Data were analyzed for 10,444 non-probabilistic internet-based survey respondents of the COVID-19 Outbreak Public Evaluation (COPE) initiative (5227 females, 5217 males).
View Article and Find Full Text PDFPriorities and Recommendations to Make ALS a Livable Disease Emanating from the 2024 National Academies of Sciences, Engineering, and Medicine Report Living with ALS.
Ann Neurol
December 2024
Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Amyotrophic lateral sclerosis (ALS) is a relentless, fatal neurodegenerative disease. The progressive loss of voluntary muscle function, diagnostic delays, lack of effective treatments, and challenges accessing multidisciplinary care and resources have tremendous impact on quality of life. The congressionally directed ALS committee of the National Academies of Science, Engineering, and Medicine, in their 2024 report "Living with ALS," recommends critical actions for specific United States stakeholders to make ALS a livable disease over the next decade.
View Article and Find Full Text PDFPlasma Ghrelin and Risks of Sex-Specific, Site-Specific, and Early-Onset Colorectal Cancer: A Mendelian Randomization Analysis.
Cancer Epidemiol Biomarkers Prev
December 2024
Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Article Synopsis
- - The study investigated the potential link between ghrelin, a hormone, and colorectal cancer using a two-sample Mendelian randomization approach, analyzing data from over 54,000 participants.
- - Results showed no significant association between genetically predicted plasma ghrelin levels and colorectal cancer risk, even when considering factors like sex, cancer subsite, and age at diagnosis.
- - The findings contribute to the existing evidence suggesting that plasma ghrelin levels do not play a causal role in the development of colorectal cancer.
Obstructive Sleep Apnea is a Risk Factor for Incident COVID-19 Infection.
medRxiv
August 2024
Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA.
Cross-sectional studies suggest that obstructive sleep apnea (OSA) is a potential risk factor for incident COVID-19 infection, but longitudinal studies are lacking. In this study, two surveys from a large general population cohort, the COVID-19 Outbreak Public Evaluation (COPE) Initiative, undertaken 147 ± 58 days apart were analyzed to determine whether the pre-existing OSA was a risk factor for the incidence of COVID-19. Of the 24,803 respondents completing the initial survey, 14,950 were negative for COVID-19; data from the follow-up survey were available for 2,325 respondents.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!